Related references
Note: Only part of the references are listed.Phase 1 Study Evaluating Safety, Tolerability, Pharmacokinetics and Immunogenicity of REGN2222 in Healthy Adults: A New Human Monoclonal RSV-F Antibody for RSV Prevention
Sumathi Sivapalasingam et al.
Open Forum Infectious Diseases (2017)
Safety, Tolerability, and Pharmacokinetics of MEDI8897, the Respiratory Syncytial Virus Prefusion F-Targeting Monoclonal Antibody with an Extended Half-Life, in Healthy Adults
M. Pamela Griffin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Anti-Viral Activities of PC786, a Novel Inhibitor of Respiratory Syncytial Virus L-Protein Polymerase
Kazuhiro Ito et al.
Open Forum Infectious Diseases (2017)
Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo(2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses
Dustin Siegel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Nanobodies®† as inhaled biotherapeutics for lung diseases
Gino Van Heeke et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Evaluation of the Financial and Health Burden of Infants at Risk for Respiratory Syncytial Virus
Stephanie McCallum Blake et al.
ADVANCES IN NEONATAL CARE (2017)
GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process
Michel Perron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection
Laurent Detalle et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Understanding respiratory syncytial virus (RSV) vaccine development and aspects of disease pathogenesis
Patricia A. Jorquera et al.
EXPERT REVIEW OF VACCINES (2016)
Molecular mechanism of respiratory syncytial virus fusion inhibitors
Michael B. Battles et al.
NATURE CHEMICAL BIOLOGY (2016)
Engineering and expression of a RhoA peptide against respiratory syncytial virus infection in plants
Benita Ortega-Berlanga et al.
PLANTA (2016)
Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses
Jennifer L. McKimm-Breschkin et al.
ANTIVIRAL RESEARCH (2016)
New antiviral approaches for respiratory syncytial virus and other mononegaviruses: Inhibiting the RNA polymerase
Rachel Fearns et al.
ANTIVIRAL RESEARCH (2016)
Taxonomy of the order Mononegavirales: update 2016
Claudio L. Afonso et al.
ARCHIVES OF VIROLOGY (2016)
Structure-guided design of small-molecule therapeutics against RSV disease
Robert Cox et al.
EXPERT OPINION ON DRUG DISCOVERY (2016)
Influence of antigen conformation and mode of presentation on the antibody and protective responses against human respiratory syncytial virus: relevance for vaccine development
Jose A. Melero
EXPERT REVIEW OF VACCINES (2016)
ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus. infection in lung transplant recipients
Jens Gottlieb et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2016)
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Travis K. Warren et al.
NATURE (2016)
Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV
M. Gordon Joyce et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Challenges and opportunities in RSV vaccine development: Meeting report from FDA/NIH workshop
Jeffrey N. Roberts et al.
VACCINE (2016)
Advances in RSV vaccine research and development - A global agenda
Deborah Higgins et al.
VACCINE (2016)
Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV
M. Gordon Joyce et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Determinants of early life immune responses to RSV infection
Tracy J. Ruckwardt et al.
CURRENT OPINION IN VIROLOGY (2016)
Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus
Jeffrey C. Boyington et al.
PLOS ONE (2016)
GS-5806 Inhibits Pre- to Postfusion Conformational Changes of the Respiratory Syncytial Virus Fusion Protein
Dharmaraj Samuel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
1,2,3,9b-Tetrahydro-5H-imidazo[2,1-a]isoindol-5-ones as a new class of respiratory syncytial virus (RSV) fusion inhibitors. Part 2: Identification of BTA9881 as a preclinical candidate
Silas Bond et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
The discovery of 1,2,3,9b-tetrahydro-5H-imidazo[2,1-a]isoindol-5-ones as a new class of respiratory syncytial virus (RSV) fusion inhibitors. Part 1
Silas Bond et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Chemotherapy of respiratory syncytial virus infections: the final breakthrough
Erik De Clercq
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Challenges and Opportunities in Developing Respiratory Syncytial Virus Therapeutics
Eric A. F. Simoes et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Respiratory Syncytial Virus Inhibitor AZ-27 Differentially Inhibits Different Polymerase Activities at the Promoter
Sarah L. Noton et al.
JOURNAL OF VIROLOGY (2015)
A Druggable Pocket at the Nucleocapsid/Phosphoprotein Interaction Site of Human Respiratory Syncytial Virus
Mohamed Ouizougun-Oubari et al.
JOURNAL OF VIROLOGY (2015)
New Host Factors Important for Respiratory Syncytial Virus (RSV) Replication Revealed by a Novel Microfluidics Screen for Interactors of Matrix (M) Protein
Sarit Kipper et al.
MOLECULAR & CELLULAR PROTEOMICS (2015)
Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study
John P. DeVincenzo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A Cysteine Zipper Stabilizes a Pre-Fusion F Glycoprotein Vaccine for Respiratory Syncytial Virus
Guillaume B. E. Stewart-Jones et al.
PLOS ONE (2015)
Neutralizing epitopes on the respiratory syncytial virus fusion glycoprotein
Jason S. McLellan
CURRENT OPINION IN VIROLOGY (2015)
Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures
Sara M. Johnson et al.
PLOS PATHOGENS (2015)
Risk of respiratory syncytial virus infection in preterm infants: reviewing the need for prevention
Haben Y. Abraha et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2015)
Mechanism of Action for Respiratory Syncytial Virus Inhibitor RSV604
SreeRupa Challa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Identification of Residues in the Human Respiratory Syncytial Virus Fusion Protein That Modulate Fusion Activity and Pathogenesis
Anne L. Hotard et al.
JOURNAL OF VIROLOGY (2015)
A population-weighted, condition-adjusted estimate of palivizumab efficacy in preventing RSV-related hospitalizations among US high-risk children
Christopher S. Ambrose et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Serum palivizumab level is associated with decreased severity of respiratory syncytial virus disease in high-risk infants
Michael L. Forbes et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Discovery of a potent respiratory syncytial virus RNA polymerase inhibitor
Hui Xiong et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
The Use of Humanized Monoclonal Antibodies for the Prevention of Respiratory Syncytial Virus Infection
Marcello Lanari et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
A Novel Influenza Virus Hemagglutinin-Respiratory Syncytial Virus (RSV) Fusion Protein Subunit Vaccine against Influenza and RSV
Tiffany M. Turner et al.
JOURNAL OF VIROLOGY (2013)
Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody
Jason S. McLellan et al.
SCIENCE (2013)
Respiratory Syncytial Virus Entry Inhibitors Targeting the F Protein
Zhiwu Sun et al.
VIRUSES-BASEL (2013)
Prophylaxis and Treatment of Respiratory Syncytial Virus in Adult Immunocompromised Patients
Lauren M. Hynicka et al.
ANNALS OF PHARMACOTHERAPY (2012)
Inhibition of Human Respiratory Syncytial Virus Infectivity by a Dendrimeric Heparan Sulfate-Binding Peptide
Manuela Donalisio et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
RNA Interference Therapy in Lung Transplant Patients Infected with Respiratory Syncytial Virus
Martin R. Zamora et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Structure of Respiratory Syncytial Virus Fusion Glycoprotein in the Postfusion Conformation Reveals Preservation of Neutralizing Epitopes
Jason S. McLellan et al.
JOURNAL OF VIROLOGY (2011)
Identification of nucleolin as a cellular receptor for human respiratory syncytial virus
Farnoosh Tayyari et al.
NATURE MEDICINE (2011)
Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years
Peter L. Collins et al.
VIRUS RESEARCH (2011)
Surfactant proteins and respiratory syncytial virus
Mika Ramet et al.
JOURNAL OF PEDIATRICS (2010)
Respiratory Syncytial Virus-Neutralizing Monoclonal Antibodies Motavizumab and Palivizumab Inhibit Fusion
Kelly Huang et al.
JOURNAL OF VIROLOGY (2010)
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis
Harish Nair et al.
LANCET (2010)
A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus
John DeVincenzo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
RNA Interference-Mediated Silencing of the Respiratory Syncytial Virus Nucleocapsid Defines a Potent Antiviral Strategy
Rene Alvarez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Antiviral efficacy of VP14637 against respiratory syncytial virus in vitro and in cotton rats following delivery by small droplet aerosol
PR Wyde et al.
ANTIVIRAL RESEARCH (2005)
Inhibitors of respiratory syncytial virus replication target cotranscriptional mRNA guanylylation by viral RNA-dependent RNA polymerase
M Liuzzi et al.
JOURNAL OF VIROLOGY (2005)
Small molecules VP-14637 and JNJ-2408068 inhibit respiratory syncytial virus fusion by similar mechanisms
JL Douglas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
YM-53403, a unique anti-respiratory syncytial virus agent with a novel mechanism of action
K Sudo et al.
ANTIVIRAL RESEARCH (2005)
Inhibition of respiratory syncytial virus fusion by the small molecule VP-14637 via specific interactions with F protein
JL Douglas et al.
JOURNAL OF VIROLOGY (2003)
Role of plasma membrane lipid microdomains in respiratory syncytial virus filament formation
LH McCurdy et al.
JOURNAL OF VIROLOGY (2003)
Isolation and characterisation of potential respiratory syncytial virus receptor(s) on epithelial cells
R Malhotra et al.
MICROBES AND INFECTION (2003)
CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein
RA Tripp et al.
NATURE IMMUNOLOGY (2001)
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus
EA Kurt-Jones et al.
NATURE IMMUNOLOGY (2000)
Share Paper
